Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 474 of 5804
-
Magic mushroom therapy for veterans: a new hope for PTSD?
Symptom relief Recruiting nowThe principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, …
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New drug hopes to shield transplanted kidneys from protein damage
Disease control OngoingThe goal of this clinical trial is to learn if Finerenone works to treat proteinuria patients after kidney transplantation. It will also learn about the safety of Finerenone. The main questions it aims to answer are: Does Finerenone lower the number of UACR values in kidney tran…
Phase: PHASE3 • Sponsor: kewen Chen,MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo therapy aims to beat tough blood cancer
Disease control Recruiting nowThe goal of this phase 2 clinical trial is to test the efficacy of decitabine and venetoclax combination chemotherapy in relapsed or refractory adult T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. This study use a modified regimen of decitabine and venetoclax.
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo trial targets blood cancers
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of surovatamig (formerly AZD0486) administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo aims to outsmart tough colorectal cancer
Disease control Recruiting nowThis study will enroll patients with colorectal cancer that is locally advanced or metastatic. The tumor must be microsatellite stable (MSS), have a tumor mutational burden that is high (TMB-H) and be kras mutated. Patients must have been treated with available approved treatment…
Phase: PHASE2 • Sponsor: Buzzard Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for breast cancer that spread to bones: drug combo trial launches
Disease control Recruiting nowThis is a phase Ib/II study evaluating the safety and efficacy of zunsemetinib (ATI-450) with capecitabine in patients with hormone receptor-positive and HER2-negative (HR+/HER2-) metastatic breast cancer (MBC).
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New chemo combo aims to cut leukemia relapse after transplant
Disease control Recruiting nowThis project is a prospective, single-center, randomized controlled clinical study. The subjects were high-risk or relapsed/refractory AML or ALL patients aged ≤ 65 years diagnosed by bone marrow cell morphology, immunology, genetics and therapeutic efficacy evaluation. The TmBU …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowthis is an investigator-initiated trial aimed at evaluating the efficacy and safety of anti-CD19/BCMA CAR-NK Cells in Patients With B cell mediated autoimmune disease.
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for brain cancer? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThe goal of Phase 1 of this clinical research study is to find the highest tolerable dose and the recommended Phase 2 dose of ivonescimab that can be given to patients who have recurrent glioblastoma. The goal of Phase 2 of this clinical research study is to learn if the recomme…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New trial aims to outsmart superbug in ICU patients
Disease control Recruiting nowCRAB infections in ICUs are on the rise, leading to higher morbidity, mortality, and healthcare costs due to resistance to most antibiotics, including carbapenems. The main resistance mechanisms include carbapenemases, efflux pumps, and changes in the bacterial cell wall. Curren…
Phase: PHASE4 • Sponsor: Clinical Hospital Centre Zagreb • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Real-world data may expand use of targeted drug for hard-to-treat breast cancer
Disease control Recruiting nowA longitudinal, non-interventional study with trastuzumab deruxtecan for patients with HER2-low expressing unresectable or metastatic breast cancer in Bulgaria and Slovenia
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New anxiety pill shows promise in major trial
Symptom relief OngoingA Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - Panorama
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThe PROCEADE PanTumor study aims to investigate M9140 in multiple tumor types which express carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) and it is therefore designed as a matrix study. This study aims to assess the antitumor activity, tolerability, safety, …
Phase: PHASE1, PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Surgery vs. new Weight-Loss drugs: which works best for severe obesity?
Disease control OngoingThe recent introduction of the new generation of anti-obesity medications (AOMs) will change the future of obesity treatment. These highly effective medications, such as high-dose semaglutide and tirzepatide, are hormone analogues that augment the incretin function and exert mult…
Phase: PHASE4 • Sponsor: Ali Aminian • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy aims to shrink head and neck tumors that resist standard treatment
Disease control Recruiting nowFicerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). This study intends to evaluate the safety and efficacy of ficerafusp alfa in combination with pembrolizumab versus placebo with pembrolizumab in …
Phase: PHASE2, PHASE3 • Sponsor: Bicara Therapeutics • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New gel could speed healing of stubborn leg wounds
Disease control Recruiting nowThe goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Phase: PHASE3 • Sponsor: TR Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New surgery combo for pancreatic cancer aims to cut complications and speed recovery
Disease control Recruiting nowThe primary objective of this clinical trial is to evaluate whether primary total pancreatectomy with simultaneous islet autotransplantation compared with pancreatic head resection (alone) can reduce perioperative morbidity and time to initiation of adjuvant therapy in patients w…
Phase: PHASE3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Allergy pill tested to protect heart attack survivors
Disease control Recruiting nowThe goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for lymphoma patients: targeted drug combo aims to delay cancer return
Disease control Recruiting nowThe purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment alone.
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Sound waves vs. dystonia: could a No-Cut brain treatment end limb twisting?
Disease control Recruiting nowThe goal of this clinical trial is to find out if a non-invasive procedure called focused ultrasound can safely and effectively treat limb dystonia in adults who have not improved with medications or botulinum toxin injections. The main questions it aims to answer are: * Does f…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC